Search Results 1-10 of 13880 for ������������������������������������:ZA31���

  1. S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma - Mayo Clinic

    Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as dexamethasone, work ...

  2. A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen - Mayo Clinic

    A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract ...

  3. Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  5. Research Themes and Focus Groups - Mayo Clinic Research

    These themes are organized to follow a classic cell signaling cascade from the plasma membrane to nuclear events: Cellular networks. About 37% of our ...

  6. A Study to Evaluate the Safety and Effectiveness of the Drug TTP399 to Target A1c in Type 2 Diabetics - Mayo Clinic

    This trial is a multi-center, adaptive, randomized, double-blind, placebo- and active- controlled, parallel group, phase 2 study in subjects with Type 2 ...

  7. Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) - Mayo Clinic

    This study will evaluate the efficacy of ranolazine as compared with placebo when used as part of standard medical therapy in chronic angina subjects with ...

  8. Sharing Mayo Clinic: An eye on the future

    I am Marge Cabanski, and at 74 years old in November 2020, I began experiencing eye irritation. It was diagnosed as Graves' disease. Though I had had my thyroid ...

  9. A Study to Test the Effectiveness and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects with Drug-resistant Epilepsy - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Seizure Detection and Warning System for Epilepsy Patients - Mayo Clinic

    The seizure detection and warning system is an ambulatory system designed to monitor and analyze EMG data to detect the onset of GTC seizures and to provide a ...